Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
603163 Acter Technology Integration Group
- 26.82
- +0.51+1.94%
Market Closed Dec 18 15:00 CST
2.68BMarket Cap27.20P/E (TTM)
26.90High26.01Low17.24KlotVolume26.12Open26.31Pre Close45.96MTurnover4.93%Turnover Ratio19.35P/E (Static)100.00MShares34.1152wk High2.50P/B938.77MFloat Cap20.8352wk Low28.94Limit Up35.00MShs Float48.79Historical High23.68Limit Down3.38%Amplitude20.83Historical Low0.80Dividend TTM26.66Avg Price7.98KlotAsk2.98%Div YieldTTM100Lot Size8.78KlotBid
Acter Technology Integration Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 1.37%1.54B | -7.37%914.83M | 19.33%486.52M | 29.27%2.17B | 28.83%1.52B | 36.79%987.59M | 21.40%407.69M | 13.63%1.68B | 6.56%1.18B | 6.60%721.98M |
| Refunds of taxes and levies | 73.44%8.95M | 526.73%8.91M | 30,439.22%1.83M | -76.91%4.87M | 3,251,073.19%5.16M | 895,110.44%1.42M | 3,675.35%5.99K | 1,112,586.24%21.09M | -41.29%158.73 | --158.73 |
| Cash received relating to other operating activities | 33.81%29.07M | -25.07%7.1M | 81.04%18.99M | -46.10%18.56M | 3.89%21.72M | 28.09%9.48M | 482.55%10.49M | 144.67%34.44M | 114.41%20.91M | 26.49%7.4M |
| Cash inflows from operating activities | 2.07%1.58B | -6.78%930.84M | 21.32%507.34M | 26.48%2.19B | 28.83%1.55B | 36.90%998.49M | 23.86%418.19M | 16.28%1.73B | 7.50%1.2B | 6.77%729.38M |
| Goods services cash paid | -1.36%1.35B | 9.45%885.96M | 23.59%453.07M | 34.41%1.81B | 49.13%1.37B | 30.98%809.45M | 6.86%366.61M | -1.49%1.34B | -10.34%919.8M | -14.17%617.98M |
| Staff behalf paid | -8.51%107.38M | 9.42%83.39M | -7.96%55.15M | 30.80%130.63M | 43.67%117.36M | 35.56%76.22M | 51.67%59.91M | 21.60%99.87M | 19.31%81.69M | 16.88%56.22M |
| All taxes paid | -13.68%48.7M | -41.71%25.29M | 9.27%19.81M | -1.65%76.65M | 4.75%56.42M | 19.43%43.38M | 23.85%18.13M | 30.37%77.94M | 34.56%53.85M | 39.49%36.32M |
| Cash paid relating to other operating activities | -18.40%49.66M | 12.81%31.35M | 181.35%15.8M | -11.43%43.97M | 58.00%60.86M | 121.58%27.79M | -43.14%5.62M | 2.03%49.64M | -11.90%38.52M | -49.05%12.54M |
| Cash outflows from operating activities | -2.96%1.56B | 7.23%1.03B | 20.78%543.83M | 30.95%2.06B | 46.85%1.61B | 32.33%956.83M | 10.61%450.27M | 1.07%1.57B | -7.15%1.09B | -11.69%723.06M |
| Net cash flows from operating activities | 138.07%21.95M | -328.38%-95.15M | -13.76%-36.49M | -17.11%133.52M | -153.25%-57.66M | 558.98%41.66M | 53.82%-32.08M | 348.53%161.09M | 281.12%108.28M | 104.66%6.32M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -46.13%160M | -38.86%115M | 5.11%60M | 183,333.97%371M | --297M | --188.11M | --57.08M | --202.25K | ---- | ---- |
| Cash received from returns on investments | --424.31K | --336.11K | --128.71K | --1.81M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --72.7K | --72.7K | --70.5K | -89.74%28K | ---- | ---- | ---- | -51.05%273.01K | 492.76%390.19K | --375.83K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | 4,805.04%2.03M | ---- | ---- | ---- | 460.29%41.35K | ---- |
| Cash inflows from investing activities | -46.33%160.5M | -38.65%115.41M | 5.46%60.2M | 78,349.49%372.84M | 69,194.32%299.03M | 49,950.65%188.11M | 69,091.51%57.08M | -14.78%475.26K | 489.49%431.53K | --375.83K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 715.84%10.07M | 624.98%8.45M | 2,463.75%5.71M | 255.36%17M | -58.94%1.23M | -61.25%1.17M | -90.79%222.57K | 154.22%4.78M | 202.42%3.01M | 244.08%3.01M |
| Cash paid to acquire investments | -0.00%175M | -25.71%130M | --75M | 104.10%249M | --175M | --175M | ---- | --122M | ---- | ---- |
| Cash outflows from investing activities | 5.01%185.07M | -21.41%138.45M | 36,161.56%80.71M | 109.81%266M | 5,761.79%176.23M | 5,759.48%176.17M | -90.79%222.57K | 6,638.18%126.78M | 202.42%3.01M | 244.08%3.01M |
| Net cash flows from investing activities | -120.01%-24.57M | -292.91%-23.04M | -136.07%-20.51M | 184.59%106.84M | 4,868.75%122.79M | 553.97%11.94M | 2,537.42%56.86M | -9,440.77%-126.31M | -179.61%-2.57M | -201.07%-2.63M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --5.4M | --3.53M | --1.68M | -99.58%2.11M | ---- | ---- | ---- | --504.55M | --504.55M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --5.4M | --3.53M | --1.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -93.80%363.06K | ---- | ---- | -97.27%6.39M | -97.44%5.86M | -98.25%2.77M | -96.77%2.74M | 22.23%233.74M | 24.55%229.08M | 43.17%158.2M |
| Cash received relating to other financing activities | --30.58M | --30.58M | ---- | --22.61M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 520.37%36.34M | 1,131.39%34.11M | -38.48%1.68M | -95.79%31.11M | -99.20%5.86M | -98.25%2.77M | -96.77%2.74M | 286.09%738.29M | 298.88%733.63M | 43.17%158.2M |
| Borrowing repayment | -98.25%351.58K | ---- | ---- | -88.07%37.84M | -92.27%20.13M | -87.74%19.93M | -64.42%19.73M | 96.00%317.11M | 183.61%260.42M | 137.06%162.57M |
| Dividend interest payment | 13.42%74.78M | 22.06%80M | ---- | 99.38%66.09M | 103.71%65.93M | 107.16%65.54M | -17.20%460.23K | 2.69%33.15M | 2.74%32.37M | 3.27%31.64M |
| Cash payments relating to other financing activities | 1,447.35%26.94M | 415.53%6.83M | 192.40%663.64K | -90.47%2.18M | 6.51%1.74M | -1.63%1.32M | -67.19%226.96K | 937.15%22.87M | 16.77%1.63M | 16.89%1.35M |
| Cash outflows from financing activities | 16.25%102.07M | 0.04%86.83M | -96.75%663.64K | -71.56%106.11M | -70.18%87.8M | -55.62%86.79M | -63.99%20.42M | 90.10%373.13M | 136.06%294.42M | 94.84%195.55M |
| Net cash flows from financing activities | 19.79%-65.73M | 37.26%-52.72M | 105.77%1.02M | -120.54%-75M | -118.66%-81.94M | -124.98%-84.02M | -163.03%-17.68M | 7,325.17%365.16M | 641.96%439.21M | -468.35%-37.35M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 28,735.25%4.86M | -228.66%-3.51M | 106.22%17.58K | 412.71%2.3M | -99.59%16.84K | 18.64%2.73M | -78.95%-282.78K | 332.55%447.89K | 8,066.74%4.07M | 801.13%2.3M |
| Net increase in cash and cash equivalents | -278.11%-63.49M | -530.01%-174.42M | -920.46%-55.96M | -58.13%167.66M | -103.06%-16.79M | 11.70%-27.68M | 115.53%6.82M | 663.20%400.39M | 37,769.18%548.98M | 75.24%-31.35M |
| Add:Begin period cash and cash equivalents | 30.91%710M | 30.91%710M | 30.60%708.31M | 282.06%542.34M | 282.06%542.34M | 282.06%542.34M | 282.06%542.34M | -33.37%141.95M | -33.37%141.95M | -33.37%141.95M |
| End period cash equivalent | 23.01%646.5M | 4.07%535.58M | 18.79%652.35M | 30.91%710M | -23.94%525.55M | 365.34%514.66M | 460.14%549.16M | 282.06%542.34M | 226.55%690.93M | 28.01%110.6M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
